Edmonton, Canada The main department of described VC is located in the Edmonton. The venture was found in North America in Canada.
Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Medwell Capital works on 4 percentage points more the average amount of lead investments. The top activity for fund was in 2011. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Medwell Capital, startups are often financed by iNovia Capital, VIMAC Milestone Medical Fund, MSBi Valorisation. The meaningful sponsors for the fund in investment in the same round are Toray Industries, Schooner Capital. In the next rounds fund is usually obtained by Schooner Capital.
Among the various public portfolio startups of the fund, we may underline Mimetogen Pharmaceuticals Among the most popular fund investment industries, there are Clinical Trials, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - Canada. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aleph Capital Partners | England, London, United Kingdom |
| Bharti Enterprises | Delhi, India, New Delhi |
| GMO | Boston, Massachusetts, United States |
| Haflo | Stockholm, Stockholm County, Sweden |
| iHealthtech ,NUS | - |
| Peet's Coffee & Tea | California, Roseville, United States |
| Perivoli Innovations | - |
| Rona Syndicates | California, San Mateo, United States |
| Wheatley MedTech Partners | - |
| Zhe Xin Ziben | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Mimetogen Pharmaceuticals | $2M | 25 Feb 2011 | Quebec |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Mimetogen Pharmaceuticals | $2M | 25 Feb 2011 | Quebec |
